• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Roche’s Divarasib Scores Phase I Win in KRAS-Mutated Solid Tumors

cafead

Administrator
Staff member
  • cafead   Aug 24, 2023 at 12:12: PM
via Roche’s Genentech on Thursday released early-stage data on its KRAS inhibitor, divarasib, as it hopes to join Amgen and Mirati in the potential blockbuster cancer market.

article source
 

<